Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Apremilast, ATC L04AA32

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 261 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Apremilast, ATC L04AA32

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

25 / 100

Risk factors

No estimated value or guaranteed volume; actual revenue depends on market share and prescriptions in Bavaria.

If a formal rebate contract (via open procedure) for Apremilast is concluded, the open house agreements automatically t...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of pharmaceutical products containing Apremilast (ATC L04AA32) under non-exclusive rebate agreements with AOK Bayern
  • Contract terms are identical for all participants, no individual negotiation
Show full summary

Open house model for non-exclusive pharmaceutical rebate agreements (Rabattverträge) for the active substance Apremilast (ATC L04AA32) by AOK Bayern. This is not a formal procurement procedure but a voluntary accession model under §130a Abs. 8 SGB V. Any interested pharmaceutical company meeting eligibility criteria can conclude a standardized, non-negotiable rebate contract. Contracts can be concluded at any time until 05.05.2027, with earliest start 01.07.2025 and latest end 30.06.2027. No estimated value provided. Only one lot covering the product.

Risks

No estimated value or guaranteed volume; actual revenue depends on market share and prescriptions in Bavaria.

If a formal rebate contract (via open procedure) for Apremilast is concluded, the open house agreements automatically t...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Eligibility: Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible

Administrative

  • Submission of signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Submission of signed contract and appendix specifying the medicinal products

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Apremilast, ATC L04AA32

Non-exclusive rebate agreements for pharmaceutical products containing Apremilast (ATC L04AA32). All interested pharmaceutical companies meeting eligibility can join. Standardized terms, no negotiation.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Deadline

Deadline May 05, 2027

Procurement Details

Publication date
15 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
318281-2025

Documents (2)

Similar tenders